Nimbus is also eligible to receive up to approximately $1.3 billion in total including development, commercial, and sales milestone payments, as well as tiered royalties on global net sales
Core Compounding Categories The pharmacy's catalog centers on hormone therapies (testosterone cypionate, estradiol, progesterone, DHEA), thyroid combinations (T3/T4 blends), peptide formulations (including BPC-157, sermorelin, and PT-141), and weight-management compounds
Cost varies by provider, dose, and program length
Yes, the starting doses of 0.25 mg and 0.5 mg are primarily designed to help your body acclimate to the medication rather than provide maximum weight loss
Tripodi M, Casertano A, Peluso M, et al